Breakthrough in Cancer Treatment: Targeting DNA Circles for Therapy

A US-UK study has identified extrachromosomal DNA (ecDNA) as a key factor in the growth and treatment resistance of aggressive cancers. Found in over 17% of tumors studied, ecDNA carries genes that drive cancer and suppress the immune system. Researchers have discovered that CHK1 inhibitors, a new class of drugs, can target and destroy tumor cells containing ecDNA, offering hope for new treatments. This breakthrough could transform the prognosis for patients with hard-to-treat cancers by cutting off the tumors' survival mechanisms.